Semaglutide has been found in studies to reduce insulin resistance, possibly because it helps you lose weight, and obesity is a factor with insulin resistance
Your gastroenterologist will give you specific instructions so the procedure is as safe and accurate as possible
Key safety risks include hypoglycaemia when combined with insulin or sulphonylureas, gastrointestinal interactions, pancreatitis, gallbladder disease, and dehydration-related acute kidney injury
The American Diabetes Association recommends the "15-15 rule" for treating hypoglycemia: consume 15 grams of fast-acting carbohydrates, wait 15 minutes, and recheck blood glucose
But in reality, choosing the better option is a fine balance between maximum weight loss potency, real-world availability, and what your body can actually tolerate
You may also have a caregiver or another person assist you by injecting the drug into the back of your upper arm